About this trial
Abstract: Studies demonstrate that the use of nutritional supplements containing beta-glucans stimulates the immune system, modulates inflammatory activity, and promotes so-called immune training. Beta-glucans are prebiotics that stimulate the growth and activity of gastrointestinal microbiota and inhibit pathogen growth. Nutritional intervention is crucial for patients\' positive evolution, and providing a supplement with highly bioavailable nutrients can make a difference in their nutritional, metabolic, and immune status. Therefore, the study aims to verify the effectiveness of the innate and adaptive immune response to a nutritionally balanced fermented food, containing oral or enteral beta-glucans, in patients treated at 3 Emergency Care Units in São José do Rio Preto, São Paulo, Brazil. This is a prospective randomized study with a characteristic design involving patients treated in the medical wards of 3 Emergency Care Unit. The following assessments will be conducted: Global Subjective Assessment for adults and Mini Nutritional Assessment for the elderly, Sociodemographic, and Laboratory Evaluation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
BioNutri AR-1,
Dietary supplementintervention with fermented and nutritionally balanced food twice a day
Treatment groups
Trial outcomes
Primary outcomes
length of hospital stay
Secondary outcomes
need for readmission
need for ICU
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Federal University of São Paulo
Lead sponsor
Kaiser Clinic and Hospital
Collaborator
This trial is not recruiting at the moment. You can still explore other options: